BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17194554)

  • 21. Hormone therapy use and prescription durations of menopausal women in Taiwan: a 5 years' National Cohort study.
    Kuo DJ; Lee YC; Huang WF
    Maturitas; 2007 Nov; 58(3):259-68. PubMed ID: 17920215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there an association between meningioma and hormone replacement therapy?
    Blitshteyn S; Crook JE; Jaeckle KA
    J Clin Oncol; 2008 Jan; 26(2):279-82. PubMed ID: 18182668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuation rate of hormone replacement therapy in Hong Kong public health sector.
    Leung KY; Ling M; Tang GW
    Maturitas; 2004 Dec; 49(4):338-44. PubMed ID: 15531131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient noncompliance with hormone replacement therapy: a nationwide estimate using a large prescription claims database.
    Faulkner DL; Young C; Hutchins D; McCollam JS
    Menopause; 1998; 5(4):226-9. PubMed ID: 9872489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
    Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
    J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time trends in cigarette smoking in two German cohorts--results from EPIC Germany.
    Rohrmann S; Kroke A; Boeing H; Becker N
    Eur J Cancer Prev; 2003 Aug; 12(4):327-32. PubMed ID: 12883387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
    Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
    Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
    Parazzini F;
    Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-reported data on reproductive variables were reliable among postmenopausal women.
    Lucas R; Azevedo A; Barros H
    J Clin Epidemiol; 2008 Sep; 61(9):945-50. PubMed ID: 18468857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone replacement therapy use over a decade in an Australian population.
    MacLennan AH; Wilson DH; Taylor AW
    Climacteric; 2002 Dec; 5(4):351-6. PubMed ID: 12626214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of hormone replacement therapy on cognitive function in post-menopausal women.
    Lavi R; Doniger GM; Simon E; Hochner-Celnikier D; Zimran A; Elstein D
    QJM; 2007 Sep; 100(9):567-73. PubMed ID: 17664220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Known risk factors do not explain disparities in gallstone prevalence between Denmark and northeast Germany.
    Friedrich N; Völzke H; Hampe J; Lerch MM; Jørgensen T
    Am J Gastroenterol; 2009 Jan; 104(1):89-95. PubMed ID: 19098855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in cigarette smoking in the German centers of the European Prospective Investigation into Cancer and Nutrition (EPIC): the influence of the educational level.
    Rohrmann S; Becker N; Kroke A; Boeing H
    Prev Med; 2003 Apr; 36(4):448-54. PubMed ID: 12649053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence with oral and transdermal hormone replacement therapy and hospitalisation for cardiovascular outcomes.
    Corrao G; Zambon A; Nicotra F; Fornari C; La Vecchia C; Mezzanzanica M; Nappi RE; Merlino L; Cesana G
    Maturitas; 2007 Jul; 57(3):315-24. PubMed ID: 17485182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users.
    Rondanina G; Puntoni M; Severi G; Varricchio C; Zunino A; Feroce I; Bonanni B; Decensi A
    J Clin Oncol; 2008 Mar; 26(9):1537-43. PubMed ID: 18349406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motives for initiation, temporary discontinuation, and permanent discontinuation of hormone replacement therapy use among Norwegian women.
    Øren A
    Maturitas; 2009 Sep; 64(1):33-7. PubMed ID: 19720480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy.
    Katalinic A; Rawal R
    Breast Cancer Res Treat; 2008 Feb; 107(3):427-30. PubMed ID: 17453336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternatives to hormone replacement therapy: a multi-method study of women's experiences.
    Wathen CN
    Complement Ther Med; 2006 Sep; 14(3):185-92. PubMed ID: 16911898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The validity of self-reported use of hormone replacement therapy among Danish nurses.
    Løkkegaard EL; Johnsen SP; Heitmann BL; Stahlberg C; Pedersen AT; Obel EB; Hundrup YA; Hallas J; Sørensen HT
    Acta Obstet Gynecol Scand; 2004 May; 83(5):476-81. PubMed ID: 15059162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.